Trouble finding your estradiol patch? Compare your options.
A refill delay should come with a plan. Start with your pharmacist and prescriber: check the exact product and strength, then discuss another available brand or formulation if needed.
What is happening with patch supply?
In its September 3, 2026 update, FDA acknowledged difficulty finding some estradiol patches while stating that patches remain available. Availability varies by brand and location, and the agency is working with all six manufacturers to increase supply. A local stock problem does not establish that every estradiol patch is unavailable. Read the FDA availability update.
What should you ask first?
Have the product name, strength, change schedule and number of patches remaining ready. Ask the pharmacy to check supply and contact your prescriber about alternatives. Do not cut patches, extend wear times or translate a patch dose into a gel or tablet dose yourself.
How do the alternatives differ?
Another patch: a different available product may be an option, with the strength and schedule confirmed by your prescriber. Transdermal gel: it also delivers estradiol through the skin, but application, absorption and transfer precautions differ. Sharing a route does not make the doses interchangeable. Oral estradiol: it uses a different route, which changes the clinical comparison. Compare patch, gel and pill.
Local vaginal therapy addresses a different treatment question from systemic therapy. The symptoms being treated, your medical history and whether you need endometrial protection belong in the prescribing decision. Estradiol prescribing information and gel application precautions provide product-specific detail.
Where do compounded preparations fit?
Compounded hormone preparations are not FDA-approved finished products, and a local refill delay does not by itself establish that compounding is appropriate. ACOG recommends approved menopausal hormone products over compounded versions when an approved option can meet the patient’s needs. Ask which product is being proposed and why it fits your situation. Read ACOG’s guidance.
Bring your current plan with you
Your existing prescription and treatment history make the conversation more useful. If you are facing a supply gap, tell the prescriber how much you have left and ask for instructions while the next prescription is arranged.
Sources
- FDA: Estradiol transdermal patch availability
September 3, 2026. Availability varies by product and location; manufacturers are increasing supply.
- Climara prescribing information
DailyMed. Systemic estradiol indications and safety.
- Estradiol gel prescribing information
DailyMed. Application instructions, indications and transfer precautions.
- ACOG: Compounded bioidentical menopausal hormone therapy
Clinical Consensus, 2023. Evidence limits and selection of approved versus compounded formulations.
